New directions in psychiatric drug development: promising therapeutics in the pipeline.

Journal: Expert opinion on drug discovery
Published Date:

Abstract

INTRODUCTION: Psychiatric disorders are a leading cause of disability worldwide, calling for an urgent need for new treatments, early detection, early intervention, and precision medicine. Drug discovery and development in psychiatry continues to expand in new and exciting areas, with several new medications approved for psychiatric indications by the U.S. Food and Drug Administration (FDA) in the last 5 years.

Authors

  • Linda S Brady
    Division of Neuroscience and Basic Behavioral Science, National Institute of Mental Health, Bethesda, MD, USA.
  • Sarah H Lisanby
  • Joshua A Gordon
    National Institute of Mental Health, Bethesda, MD, USA.